The Japan Robotic Surgery Service market size was valued at $267 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 19.8% % from 2022 to 2030 and will reach $1131 Mn in 2030. The robotic surgery service market will grow due to the development of new and improved robotic surgical systems is making these procedures more accessible and affordable, and helping to increase awareness about their benefits among healthcare providers and patients. The market is segmented by product and service type, application type, and end user. Some of the major players are Stryker Corporation, Smith & Nephew, TransEnterix Surgical, Inc., and others
The Japan Robotic Surgery Service market size was valued at $267 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 19.8% % from 2022 to 2030 and will reach $1131 Mn in 2030. Japan has one of the highest levels of healthcare spending in the world, with health expenditure accounting for a significant portion of the country's gross domestic product (GDP).
According to data from the World Health Organization (WHO), Japan's total health expenditure was estimated to be 9.0% of its GDP, which is higher than the average for developed countries. This high level of spending is due in part to Japan's aging population and the associated increase in demand for healthcare services.
In Japan, the majority of healthcare spending is covered by the country's public health insurance program, which is funded through a combination of payroll taxes and premiums paid by individual citizens. Private health insurance is also available, but it covers a relatively small portion of total health expenditure. In recent years, Japan has been facing increasing pressure to control healthcare costs and ensure the sustainability of its public health insurance program. The government has implemented several measures to address these concerns, including reforms to the fee schedule for medical services, efforts to promote the use of generic drugs, and initiatives to encourage the development of more cost-effective medical technologies.
In Japan, the provision of robotic surgery services is expanding quickly. In Japan, interest in using surgical robots has grown over the past ten years due to factors such as technological advancements, rising prosperity, and a rising need for high-quality medical care.
Numerous procedures, including minimally invasive surgery for diseases including cancer, heart disease, and gynecological issues, use robotic surgical equipment. They have a number of benefits over conventional surgical methods, such as increased accuracy, a lower chance of complications, and quicker recovery times. The market for robotic surgical services in Japan is anticipated to expand quickly over the next few years due to rising healthcare investment, rising demand for high-quality medical services, and technological advancements. This expansion is anticipated to create new opportunities for both existing market participants and up-and-coming players, as well as to increase Japanese citizens' access to high-quality, reasonably priced healthcare.
Market Growth Drivers
The Japanese market for robotic surgery services has been growing in recent years, driven by several factors:
Market Restraints
Key Players
Policy changes and Reimbursement scenario
Ministry of Health, Labour and Welfare (MHLW): The MHLW is responsible for overseeing the approval and regulation of medical devices, including robotic surgical systems, in Japan. The MHLW sets standards for the safety and efficacy of these devices, and reviews and approves applications for their use in the Japanese market.
Japan Medical Device Nomenclature (JMDN): The JMDN is a classification system used by the MHLW to categorize medical devices based on their intended use, level of risk, and regulatory requirements. Robotic surgical systems are classified as Class III medical devices, which are subject to the highest level of regulatory oversight in Japan.
National Health Insurance (NHI): The NHI is Japan's national health insurance system, which covers the majority of the country's population. The NHI covers a wide range of medical procedures, including those performed using robotic surgical systems. However, the level of reimbursement for these procedures can vary depending on the type of procedure and the patient's insurance coverage.
In general, the regulation and reimbursement of robotic surgeries in Japan are designed to ensure the safety and efficacy of these procedures, while also promoting access to these services for patients. The Japanese government has taken a proactive approach to promote the use of advanced medical technologies, including robotic surgical systems, in order to improve patient outcomes and enhance the quality of healthcare in the country. However, like in any healthcare system, there are always challenges and limitations when it comes to reimbursement and regulations, and these can impact the availability and affordability of these services.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Product and Services (Revenue, USD Billion):
The surgical robotics market volume data has been covered for all the major surgical robotics systems. In terms of value, the surgical systems market is anticipated to expand at a CAGR of 11.22% from 2018 to 2025.
By Application (Revenue, USD Billion):
Gynecology accounted for the largest market share in 2017 and is anticipated to expand at a CAGR of 7.0% from 2018 to 2025. This is explained by the rising prevalence of gynecological complications in women worldwide and the ongoing development of robotic technologies.
By End User (Revenue, USD Billion):
The hospitals' segment had the largest market value in 2017 and experienced a CAGR of 13.20% from 2018 to 2025. However, during the projected period of 2018–2025, the ambulatory surgical center's income is predicted to rise at the highest CAGR of 18.20%.
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.